BioSig Technologies, Inc. 8-K Filings

Streamex Corp. filed an 8-K to announce that it has appointed Kori Handy as Vice President of Product and Design. He brings 18 years of experience building and scaling fintech and SaaS products at companies such as Microsoft, PayPal, DraftKings, Expedia, Groundfloor, and others.

Handy will lead product strategy and design for Streamex’s GLDY gold-backed, yield-bearing tokenized security and the broader Streamex ecosystem, focusing on customer experience, design systems, onboarding, and new investor-facing products as the company moves from infrastructure buildout to platform scale and mass-market expansion.

Streamex Corp. reported several leadership and compensation changes. The board appointed Chief Investment Officer Mitchell Young Williams as a non-independent director, with his board term running until the 2026 annual stockholder meeting unless ended earlier.

The company amended employment agreements for Mr. Williams, CEO Karl Henry McPhie, and Interim Executive Chairman Morgan Lekstrom, each setting a $350,000 annual base salary and minimum $100,000 bonus for 2026. Williams received 2,250,000 restricted stock units that vest quarterly and accelerate upon certain termination or change-in-control events. McPhie and Lekstrom each received 1,500,000 performance stock units vesting in tranches tied to cumulative GLDY sales milestones from US$250 million up to US$3 billion, plus potential one-time cash and stock awards if fully diluted market capitalization reaches $50 billion, $100 billion, and $500 billion. All three executives are entitled to severance, continued benefits, prorated bonus, and accelerated equity vesting if terminated without cause or resigning for good reason.

Streamex Corp. furnished an investor presentation linked to a webcast held on April 8, 2026, where management discussed financial results for the year ended December 31, 2025 and provided corporate updates. The slide deck is available on the company’s investor website and is included as Exhibit 99.1.

The company states this information is being provided under Regulation FD and is treated as “furnished,” not “filed,” so it is not subject to Section 18 liability nor automatically incorporated into other securities law filings unless specifically referenced.

Streamex Corp. entered into voluntary one-year lock-up agreements with its co-founders, Chief Executive Officer Henry McPhie and Executive Chairman Morgan Lekstrom. For one year from March 26, 2026, they agreed not to sell or transfer any Streamex common stock or related convertible securities, subject to limited exceptions such as bona fide gifts and transfers to certain family-related entities.

The company also clarified that third-party posts about an alleged March 24, 2026 lock-up expiration and 89,833,535 shares under lock-up were inaccurate. It stated that earlier, customary 60-day lock-ups covered 42,887,599 shares, including 21,014,450 shares held by McPhie and 20,707,421 held by Lekstrom, and that shares issued in the January 26, 2026 financing were freely tradable at closing.

Streamex Corp. reported a leadership transition in its finance organization. Ferdinand Groenewald resigned as Chief Financial Officer, effective March 15, 2026, under a Separation Agreement that provides $112,500 in cash severance (six months of base salary), pro-rated 2025 and 2026 bonuses if paid to other senior executives, and up to 12 months of COBRA reimbursement. His prior 500,000 restricted stock units were amended to 301,500 units, all of which, along with 60,000 restricted shares, fully vested on the separation date, and his Streamex shares are subject to a six‑month lock‑up.

The company also agreed to settle certain tax liabilities from earlier restricted stock awards and engaged an affiliate, Groenewald Enterprises LLC, under a six‑month consulting agreement at $20,000 per month. Streamex appointed Christine Plummer, a veteran finance executive with senior roles at Coinbase, MSCI and Morgan Stanley, as the new Chief Financial Officer under an employment agreement providing a $350,000 base salary, eligibility for an annual bonus, and a grant of 500,000 RSUs vesting quarterly over 48 months, along with severance and accelerated vesting protections for certain terminations and change in control events.

Streamex Corp. announced the appointment of Shawn Matthews, founder and CIO of Hondius Capital Management and former CEO of Cantor Fitzgerald & Co., as an independent director and member of its Compensation Committee. His term runs until the next annual stockholder meeting or until a successor is elected.

Under an offer letter dated March 3, 2026, Matthews will receive non-employee director pay consistent with company policy, including a $40,000 annual cash retainer, an additional $25,000 annual retainer for each Board committee he serves on, and a restricted stock award of 100,000 common shares. He is eligible for further annual equity awards and will receive standard director indemnification and directors and officers liability insurance coverage.

Streamex Corp. has fully settled its secured convertible debentures with YA II PN, LTD., ending this financing arrangement and related security interests. On February 6, 2026, the holder converted $15,000,000 of principal at $4.00 per share, issuing 3,750,000 common shares under an existing shelf registration.

After the conversion window expired, Streamex prepaid the remaining amounts for a total of $38,902,740, including $35,000,000 of principal, a $3,500,000 prepayment premium, and $402,740 of accrued interest. The company also cancelled its unused Standby Equity Purchase Agreement with Yorkville, describing these steps as removing debt and dilution overhang and leaving a clean balance sheet.

Governance-wise, co-founder and Chairman Morgan Lekstrom has been appointed Executive Chairman and joins the executive leadership team, with compensation details to be determined. Streamex also filed a prospectus supplement to register for resale 2,443,750 previously issued common shares held by Terra Capital Natural Resources Fund Pty Ltd.

Streamex Corp. appointed Anthony Marciano, a Clinical Professor of Finance at NYU Stern, as an independent director and member of the Audit Committee. His term runs until the next annual stockholder meeting or until a successor is elected and qualified.

Marciano brings more than 40 years of experience in finance and academics, including senior roles at Goldman Sachs, Morgan Stanley, and Drexel Burnham Lambert, and teaching positions at NYU Stern, MIT Sloan, and the University of Chicago. Under Streamex’s current non-employee director policy, he will receive a $40,000 annual cash retainer plus $25,000 per Board committee, and is eligible for annual equity awards.

Streamex Corp. entered into an Underwriting Agreement with Needham & Company for a public offering of 11,666,667 shares of common stock at $3.00 per share. The offering, made under an effective Form S-3 shelf registration, closed after the shares were sold to the underwriters.

On January 27, 2026, the underwriters fully exercised their over-allotment option to purchase an additional 1,750,000 shares at the public offering price, bringing aggregate gross proceeds to the company to $40.25 million before underwriting discounts and expenses. The company plans to use net proceeds to repay prior indebtedness, and for working capital and general corporate purposes.

The agreement includes customary representations, indemnification provisions, and a 60-day lock-up under which the company, as well as its officers and directors, agreed not to offer or transfer common stock, subject to specified exceptions. Streamex also obtained a legal opinion on the validity of the shares and issued multiple press releases announcing the launch, pricing, closing, and over-allotment closing of the offering.

Streamex Corp. terminated its Standby Equity Purchase Agreement with YA II PN, Ltd. (“Yorkville”), effective five trading days after a January 22, 2026 notice, and confirmed it has not sold any securities under that facility. The company also moved to fully address its secured convertible debentures held by Yorkville.

On the same date, Streamex delivered an irrevocable optional prepayment notice for its secured convertible debentures dated November 4 and December 17, 2025, with an original aggregate principal amount of $50,000,000. Yorkville has ten trading days from the notice date to elect conversion, after which any remaining balance must be prepaid at principal plus a 10% prepayment premium and accrued interest, with related security interests released once paid in full.

The company disclosed that, if conversions are not completed before the prepayment date, it may liquidate allocated vaulted gold bullion credited to a pledged account to fund the prepayment. Streamex furnished a press release about the SEPA termination and debenture repayment as Exhibit 99.1, noting this information is being furnished rather than filed for Exchange Act liability purposes.

Streamex Corp. filed an amended current report to correct how it previously described the outcome of Proposal 6 at its September 5, 2025 special stockholder meeting. The proposal sought to amend the company’s Certificate of Incorporation to create a classified board of directors with three classes serving staggered three-year terms. The company now states that, although 15,424,979 votes were cast "for", 1,009,783 "against", with 203,852 abstentions and 3,483,433 broker non-votes, the proposal did not receive the required affirmative vote of a majority of the outstanding voting power under Section 242 of the Delaware General Corporation Law. The company nonetheless had filed a charter amendment reflecting adoption of the classified board structure on November 19, 2025 and held its December 30, 2025 annual meeting in accordance with that structure.

Streamex Corp. entered into a Share Purchase Agreement with Terra Capital Natural Resources Fund Pty Ltd on December 11, 2025 to acquire a 9.9% equity interest in Empress Royalty Corp. Streamex is acquiring 12,671,297 shares of Empress common stock in exchange for issuing 2,443,750 shares of its own common stock at an implied price of US$5.00 per STEX share.

The exchange values the transaction at C$17,106,251.62, or US$12,218,751.00 in aggregate. Streamex explains that the deal gives it direct exposure to Empress’ portfolio of gold and silver royalty and streaming assets, supporting its strategy of expanding into real-world, yield-generating commodity assets alongside regulated digital asset infrastructure. The share issuance was an unregistered sale of equity securities with no underwriters or placement agents involved.

Streamex Corp. reported significant governance and leadership changes. Three directors — Steven Abelman, Christopher Baer and Anthony Amato — resigned effective immediately, each stating the decision was not due to any disagreement with the company. The board appointed Kevin Gopaul as an independent Class II director and member of all key committees, with an annual cash retainer of $40,000 plus $25,000 for each committee under the current policy.

The company entered new agreements with its top leaders. Chief Executive Officer Karl Henry McPhie will receive a $225,000 base salary, a target bonus equal to 65% of salary, and, subject to stockholder approval, 100,000 fully vested shares and 900,000 restricted stock units vesting over four years, along with double-trigger severance and equity acceleration protections. Chief Financial Officer Ferdinand Groenewald will receive the same base salary, a 65% target incentive mix of cash and equity, and, subject to stockholder approval, 100,000 shares and 400,000 RSUs, with tiered severance and COBRA benefits.

Chairman Morgan Lekstrom entered a Chairman Agreement providing a $40,000 board retainer, a $99,000 chairman retainer, and 100,000 shares vesting over one year subject to stockholder approval. Separately, a charter amendment created a classified board structure with directors divided into three staggered classes, setting multi‑year terms for Lekstrom, McPhie, Gopaul and Donald Browne.

Streamex Corp. (BSGM) entered a financing and issued a secured convertible debenture. On November 4, 2025, the company closed an initial tranche with a principal amount of $25,000,000, delivering approximately $24,000,000 in gross proceeds. The debenture matures on November 4, 2027 and bears 4.00% interest, increasing to 18.00% upon an event of default.

The investor may convert principal and accrued interest at the lower of a fixed price of $6.016 per share (subject to a one-time downward reset tied to post-effectiveness VWAP) or 97.0% of the lowest daily VWAP during the three trading days before conversion, with a $4.00 per-share floor. A 4.99% beneficial ownership cap applies. The company may prepay with a 10% premium, and the debenture is secured by U.S. and Canadian guarantees and security agreements.

Directors, officers, and certain shareholders agreed to 180-day lock-ups. Streamex agreed to register the resale of conversion shares under a registration rights agreement. Yorkville may purchase a second $25,000,000 debenture upon conditions and additional debentures up to $50,000,000 upon mutual agreement.

Streamex Corp. (formerly BioSig Technologies) announced that stockholders approved the Acquisition Proposal to issue approximately 109,070,079 shares of common stock and one share of Super Voting Preferred Stock under the Share Purchase Agreement dated May 23, 2025, as amended. The proposal passed with 16,386,371 votes for, 267,215 against, and 27,673 abstentions. The company stated the acquisition of Streamex Exchange Corporation has closed.

The vote occurred at a reconvened special meeting on November 4, 2025. The company also furnished an investor presentation as Exhibit 99.1 under Regulation FD, which is not deemed filed. Streamex’s common stock trades on Nasdaq under the symbol STEX.

Streamex Corp. announced Nasdaq’s formal approval for the continued listing of its common stock on the Nasdaq Capital Market under the ticker STEX.

The company also set a reconvened special meeting of stockholders to vote on Proposal 1 – the Acquisition Proposal at 3:00 p.m. Eastern Time on November 4, 2025. The meeting will be held via webcast at www.virtualshareholdermeeting.com/BSGM2025SM, and stockholders of record as of the applicable record date may attend, vote, and ask questions online.

The disclosure was furnished under Regulation FD, with additional details provided in an accompanying press release (Exhibit 99.1).

Streamex Corp. entered a Second Amendment to its Secured Convertible Debenture Purchase Agreement with Yorkville, supporting a program for up to $100,000,000 in convertible debentures. The company plans to issue a $25,000,000 first convertible debenture that matures in 24 months and bears 4.00% interest, rising to 18.00% upon default. Closing is conditioned on maintaining Nasdaq listing approval.

The debenture is convertible at the lower of a fixed price set at 125% of the VWAP prior to first closing (with a one‑time downward reset tied to the Resale Registration Statement’s effectiveness window) or 97.0% of the lowest daily VWAP over the prior three trading days, with a $4.00 floor, subject to anti‑dilution adjustments and a 19.99% cap under Nasdaq rules. At least $25.1 million of proceeds—$12.6 million at first closing and $12.5 million at second closing—must be deposited to purchase Allocated Vaulted Gold Bullion as collateral. Obligations are secured by a first‑priority lien on substantially all assets. The securities will be issued in reliance on Section 4(a)(2) and/or Regulation D.

BioSig Technologies, Inc. filed an amendment to its certificate of incorporation to change its corporate name to Streamex Corp. This Name Change was approved by the Board of Directors and, according to the company, does not affect the rights of existing security holders.

Effective before the open of trading on September 12, 2025, the company’s common stock will stop trading under its prior ticker and begin trading on the Nasdaq Stock Market under the new symbol “STEX”. The CUSIP number will remain the same, and existing stock certificates with the old corporate name will continue to be valid, with new certificates issued over time as shares are exchanged or transferred.

Under Section 242 of the Delaware General Corporation Law, stockholder approval was not required for this Name Change. The company also issued a press release on September 10, 2025 announcing the new name and ticker, which has been furnished as an exhibit.

BioSig Technologies, Inc. entered a three-year Tokenized Yield Partnership Agreement with Monetary Metals & Co. to create and distribute blockchain-based products that tokenize yield from precious-metal lease and bond programs. The partnership includes mutual exclusivity for tokenizing yield from precious-metal leases, subject to volume-based performance thresholds and a ninety-day cure period if supply falls short. Each quarter, BioSig must supply at least 10% of qualifying leased ounces, while Monetary Metals will offer at least 90% of the gold under management supplied by BioSig as Passing Leases. BioSig will receive discounted fees and quarterly cash rebates on gold purchases, plus a quarterly revenue share of 0.35% to 0.50% on supplied gold deployed in Passing Leases, and will own the intellectual property for the tokenized yield products.

BioSig Technologies, Inc. (BSGM) filed an Form 8-K dated September 5, 2025 reporting corporate governance actions. The filing lists Item 5.03 (submission of matters to a vote of security holders) and includes two exhibits: a Ninth Certificate of Amendment (Exhibit 3.1) and an Incentive Plan Amendment (Exhibit 10.1). The cover page also references an Inline XBRL interactive data file. The form is signed by Karl Henry McPhie, Chief Executive Officer.

BioSig Technologies, Inc. completed an underwritten public stock offering of 3,852,149 shares of common stock at $3.90 per share. This transaction is expected to generate aggregate gross proceeds of approximately $15.02 million before underwriting discounts, commissions, and expenses.

The company plans to use the net proceeds to purchase gold bullion under its investment policy, and for working capital and general corporate purposes. BioSig, its officers, directors, and certain stockholders agreed to 90-day lock-up arrangements that restrict most additional share offerings or transfers during that period. The deal was conducted under an existing Form S-3 shelf registration and supported by a legal opinion on the validity of the shares.

BioSig Technologies amended a secured convertible debenture purchase agreement with YA II PN, Ltd. (Yorkville). The Amendment revises the transaction structure to provide a first secured convertible debenture in the principal amount of $25,000,000 and a second secured convertible debenture in the principal amount of $25,000,000, with additional secured convertible debentures available in an aggregate principal amount of up to $50,000,000 only upon mutual agreement of the parties.

The Amendment also modifies certain purchase, closing and stockholder approval provisions and updates related terms, including setting the conversion floor price at 20% of the Nasdaq Official Closing Price immediately prior to the date of entry into the original Debenture Purchase Agreement. The full Amendment is filed as Exhibit 10.1.